High Fear of Cancer Recurrence in Chinese Newly Diagnosed Cancer Patients-Reference-Cited by-同舟云学术

High Fear of Cancer Recurrence in Chinese Newly Diagnosed Cancer Patients

Published:2020-06-09 Issue: Volume:11 Page:
ISSN:1664-1078
Container-title:Frontiers in Psychology
language:
Short-container-title:Front. Psychol.

Author:

Luo Xian,Li Wengao,Yang Yuan,Humphris Gerald,Zeng Lijuan,Zhang Zijun,Garg Samradhvi,Zhang Bin,Sun Hengwen

Funder

Guangzhou Municipal Science and Technology Project

Publisher

Frontiers Media SA

Subject

General Psychology

Reference56 articles.

1. Emotional distress: the sixth vital sign–future directions in cancer care.;Bultz;Psychooncology,2006

2. Concerns, coping and quality of life in head and neck cancer patients.;Chaturvedi;Support Care Cancer,1996

3. Diagnostic test of screening depressive disorder in general hospital with the patient health questionnaire (in Chinese).;Chen;Chin. Ment. Health,2015

4. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.;DiMatteo;Arch. Intern. Med.,2000

5. Quality of life in adult survivors of childhood cancer.;Dolgin;Soc. Work. Health Care,1999

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of repetitive transcranial magnetic stimulation on fear of cancer recurrence and its underlying neuromechanism;Contemporary Clinical Trials Communications;2024-06

2. Dysfunctional Self-Focus and Fear of Progression in Cancer Patients Mediated by Depression, Anxiety, and Dysfunctional Sleep Beliefs;Psychiatry Investigation;2024-05-25

3. Fear of Recurrence in Advanced Cancer Patients: Sociodemographic, Clinical, and Psychological Correlates;Cancers;2024-02-23

4. The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study;BMC Public Health;2024-02-12

5. Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage‐IV breast cancer in Shandong, China;Cancer Medicine;2024-02